Charles Blazey

Charles (Chip) Blazey currently serves as Executive Director at Exelixis since October 2012, leading a team of nine medical writers focused on the preparation of regulatory documents for oncology indications. Previous experience at Exelixis includes roles as Senior Director, Medical Writing; Director, Medical Writing; Associate Medical Writing Director; and Senior Medical Writer 2, spanning from 2002 to 2012. Earlier in the career, Charles held the position of Senior Scientist I in Medicinal Chemistry at Merck & Co., Inc. from 1995 to 1997, and began as a Research Assistant in Medicinal Chemistry during the same period. Charles holds a B.A. in Chemistry from Cornell University and a Ph.D. in Organic Chemistry from the University of California, Berkeley.